Format

Send to

Choose Destination
Head Neck. 2009 Jul;31(7):911-8. doi: 10.1002/hed.21040.

Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC.

Author information

1
Department of Otolaryngology, University of Iowa, Iowa City Veterans Administration Medical Center, Iowa City, Iowa, USA.

Abstract

BACKGROUND:

To investigate whether human papilloma virus (HPV)-specific immune mechanisms can result in tumor clearance, we have created HPV+ and HPV- tonsil cells that form squamous cancers in immune-competent mice. Here, we determine that an immune-specific response can clear HPV+ tumor cells and the cellular requirements to mediate this tumor clearance.

METHODS:

Through the benefit of this model, we use in vitro and in vivo methods to better understand how HPV+ cells are rejected. RESULT.: The data show that an in vivo antigen-specific antitumor response is generated to HPV+ transformed cells and that this response requires CD4+ and CD8+ cells to mount this antitumor response.

CONCLUSION:

The findings from this preclinical model will have implications not only in understanding human disease but also as a valuable model for testing immunotherapeutic strategies for HPV+ head and neck cancer.

PMID:
19283850
DOI:
10.1002/hed.21040
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center